Anti-Leukemic Effect of DNA Methyltransferase Inhibitor on Cell Lines Derived from Myeloid Leukemia in Down Syndrome

被引：0
|
作者：
Tanaka, Tatsuhiko [1 ]
Kudo, Ko [1 ]
Kanezaki, Rika [1 ]
Kobayashi, Akie [1 ]
Sato, Tomohiko [1 ]
Kamio, Takuya [1 ]
Sasaki, Shinya [1 ]
Toki, Tsutomu [1 ]
Ito, Etsuro [2 ]
Terui, Kiminori [1 ]
机构：
[1] Hirosaki Univ, Dept Pediat, Grad Sch Med, Hirosaki, Aomori, Japan
[2] Hirosaki Univ, Dept Community Med, Grad Sch Med, Hirosaki, Aomori, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS2-7
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PI-103, a dual inhibitor of class I phosphatidylinositide 3-kinase and mTOR, has anti-leukemic activity in acute myeloid leukemia
    Park, Sophie
    Chapuis, Nicolas
    Bardet, Valerie
    Willems, Lise
    Tarnburini, Jerome
    Knight, Zachary A.
    Shokat, Kevan M.
    Azar, Nabih
    Ifrah, Norbert
    Dreyfus, Francois
    Mayeux, Patrick
    Lacombe, Catherine
    Bouscary, Didier
    BLOOD, 2007, 110 (11) : 268A - 268A
  • [42] Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia
    Jang, Ji Eun
    Kim, Soo Jeong
    Cheong, June-Won
    Hyun, Shin Young
    Kim, Yun Deok
    Kim, Yu Ri
    Kim, Jin Seok
    Min, Yoo Hong
    ANNALS OF HEMATOLOGY, 2015, 94 (02) : 275 - 282
  • [43] ANTI-LEUKEMIC EFFECT OF SODIUM METAARSENITE (KML001) IN ACUTE MYLOGENOUS LEUKEMIA WITH BREAKING-DOWN THE RESISTANCE OF CYTOSINE ARABINOSIDE
    Lee, Y.
    Yoon, S. S.
    Kim, E. S.
    Kim, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 269 - 269
  • [44] Effect of aplidina (APL) in leukemia cell lines and cells from acute myeloid leukemia
    Grossi, A
    Biscardi, M
    Gavazzi, S
    Balestri, F
    Bonolis, M
    Caporale, R
    Leoni, F
    Jimeno, J
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 145 - 146
  • [45] Effect of aplidine in leukemia cell lines and cells from acute myeloid leukemia.
    Grossi, A
    Biscardi, M
    Caporale, R
    Gavazzi, S
    Balestri, F
    Bonolis, M
    Jimeno, JM
    BLOOD, 2003, 102 (11) : 205B - 205B
  • [46] Anti-Leukemic Activity of the TYK2 Selective Inhibitor Ndi-031301 in T-Cell Acute Lymphoblastic Leukemia
    Akahane, Koshi
    Li, Zhaodong
    Etchin, Julia
    Berezovskaya, Alla
    Gjini, Evisa
    Masse, Craig E.
    Miao, Wenyan
    Rocnik, Jennifer
    Kapeller, Rosana
    Greenwood, Jeremy R.
    Tiv, Hong
    Sanda, Takaomi
    Weinstock, David M.
    Look, A. Thomas
    BLOOD, 2016, 128 (22)
  • [47] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
    I Cristóbal
    L Garcia-Orti
    C Cirauqui
    M M Alonso
    M J Calasanz
    M D Odero
    Leukemia, 2011, 25 : 606 - 614
  • [48] c-myc expression in cell lines derived from chronic myeloid leukemia
    Gómez-Casares, MT
    Vaqué, JP
    Lemes, A
    Molero, T
    Delgado, MD
    León, J
    HAEMATOLOGICA, 2004, 89 (02) : 241 - 243
  • [49] ANTI-LEUKEMIC EFFECT OF ALKYL PHOSPHOLIPIDS .1. INHIBITION OF PROLIFERATION AND INDUCTION OF DIFFERENTIATION OF CULTURED MYELOID-LEUKEMIA CELLS BY ALKYL ETHYLENEGLYCOPHOSPHOLIPIDS
    HONMA, Y
    KASUKABE, T
    OKABEKADO, J
    HOZUMI, M
    TSUSHIMA, S
    NOMURA, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (02) : 73 - 76
  • [50] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
    Cristobal, I.
    Garcia-Orti, L.
    Cirauqui, C.
    Alonso, M. M.
    Calasanz, M. J.
    Odero, M. D.
    LEUKEMIA, 2011, 25 (04) : 606 - 614
12345